CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study-Reference-Cited by-同舟云学术

CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study

Published:2023-07 Issue:7 Volume:10 Page:e521-e529
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Peterlin Pierre,Le Bris Yannick,Turlure Pascal,Chevallier Patrice,Ménard Audrey,Gourin Marie-Pierre,Dumas Pierre-Yves,Thepot Sylvain,Berceanu Ana,Park Sophie,Hospital Marie-Anne,Cluzeau Thomas,Bouzy Simon,Torregrosa-Diaz Jose-Miguel,Drevon Louis,Sapena Rosa,Chermat Fatiha,Ades Lionel,Dimicoli-Salazar Sophie,Chevret Sylvie,Béné Marie-Christine,Fenaux Pierre

Funder

Jazz Pharmaceuticals Inc Ewing

Jazz Pharmaceuticals

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Myelodysplastic syndromes;Cazzola;N Engl J Med,2020

2. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel;de Witte;Blood,2017

3. Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukaemia: results of the BMT-AZA prospective study;Voso;Ann Oncol,2021

4. Comparison between 5-azacytidine treatment and allogeneic stem-cell transplantation in elderly patients with advanced MDs according to donor availability (VidazaAllo Study);Kröger;J Clin Oncol,2021

5. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy;Fenaux;Br J Haematol,1991

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

3. Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC);Bulletin du Cancer;2024-09

4. Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes;Seminars in Hematology;2024-08

5. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30